chrisvoncsefalvay/vaers-outcomes huggingface dataset:
mom called 21AUG97 to report child had rxn to vax given 14AUG97;pt devel temp of 102.5 ax PM;it also had a pin point red rash all over according to mom pt also had OM;
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 30-DEC-2014, the patient was administered an expired dose of M-M-R II albumin (dose, route of administration, anatomical location were not reported) batch # J008882, lot # 0293AA expiration date 27-JUL-2014. No adverse events were reported. Additional information has been requested.
Pain in left arm near injection sight; pain when pressed or when arm raised and using the muscles in that area. Slight tickle in back of throat.
On 6-26-12 Pneu vaccine admin RA SQ 0.5 cc. 6-27-12 Patient called pain, swelling, antibiotic refused.
Within 24 hrs of receiving the Moderna vaccine I began to feel malaise. Within 36 hrs, I began an exacerbation of mouth ulcers which I had previously controlled by not using tooth paste with Sodium Laureth Sulfate. The malaise and oral cavity ulcerations became increasingly worse as days passed. At one time during the week following the vaccine I had 6-7 ulcerations in my mouth on my gums, tongue and down into my throat. Malaise continued thru Sunday, January 10. My energy level picked up beginning Monday, Jan. 11. Tuesday, January 14, 2021, I was back to baseline on energy. Also, as of the same date, the oral cavity ulcerations were resolved and no new ones formed. I ran a low grade fever on Saturday, Jan. 9 and the remainder of the post-vaccine week I was afebrile. Beginning Jan. 7 (72 hrs after administration of the vaccine)  I had a slightly irritating headache thru Sunday, Jan. 10. The headache was resolved on Monday, Jan. 11 when I awakened.
Expired doses; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment history was reported.
Redness, skin rash, swelling. BENADRYL and hydrocortisone.
Fatigue, nausea, vomiting, respiratory problems, asphyxiating attacks, mental health problems, chronic headaches, back problems, muscle spasms, neuritis, joint disorders, chronic pain on entire left side of the body, blackouts, joint pain, muscle pain, scoliosis, vitamin deficiencies.
2 pinkish blotches around bicep/tricep area way below deltoid/area of injection.  Onset about 12 hours after injection and lasted about 2-3 days.  Blotches/rash were a little itchy, hot to touch, and about 2-3 inches in diameter.  Denied fever.
Patient lost memory, had vomiting, and very tired, patient had incontinence. patient also went into afib.
Vaccine #1:  Eight days after receiving had a delayed reaction involving very intense swelling and itching of Rt. arm injection site. There was a hot red rash and swelling with a large ridge surrounding it around the entire right deltoid and slightly down the right arm. It persisted for 3 days and gradually subsided.  Benedryl was taken on the first day for the itching.   Vaccine #2: A less intense but very similar reaction occurred on the third day after injection on the Lft. arm injection site. It subsided after 2 days.
SEVERE HA , DOCTORS SAYS SE HAD ISCHEMIC STROKE , NOT SURE IF RELATED TO THE VACCINE  What happened as a result of the adverse event? SAW DOCTOR
Begin with a sore throat the next day with onset of coughing that I still have today.  1st doctor gave antibiotic steroid pak, steroid shot and antibiotic.  I have not taken antibiotic, since 2006.  That did not work.  Coughing became worse.  To the point of vomiting.  I went to a different doctor and he preformed a lung x-ray and CT scan and gave me 750 mg. of Levaquin for 5 days.  This still did not work.  I returned to doctor on 12/17/2013.  Given an inhaler, nasal spray and more Levaquin 750 mg.  On last two days and still not working.
Information has been received from a person in a physician's office concerning a 6 year old white female, who on May 27,2000 was vaccinated with a first subcutaneous dose of varicella virus vaccine live (Oka/Merck) (Lot# 635983/0449K). There was no illness at the time of vaccination. On October 22, 2005, the patient experienced 15-20 lesions, tiny vesicles and papules on her neck and trunk. Subsequently, the patient recovered. There were no laboratory or diagnostic tests performed. Additional information is not expected.
intense pain in all my teeth; This is a spontaneous report from a contactable healthcare professional (patient). This 31-year-old patient of unspecified gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EK9231) via an unspecified route of administration in the left arm on 20Jan2021 at 10:00 (at 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) from an unknown date for an unknown indication. The patient previously received the first dose of BNT162B2 (lot number EH9899) in the left arm on 30Dec2020 at 08:00 (at 31-years-old) for COVID-19 immunisation. Prior to vaccination the patient did not receive any other vaccines in 4 weeks, had no allergies and was not diagnosed with COVID-19. On 21Jan2021 the patient reported waking up at midnight with intense pain in all their teeth as if chewing on raw sugar mixed with tin foil. No treatment was received for the events. The outcome of the event was recovered on an unspecified date in 2021. Since vaccination the patient had tested positive for COVID on 23Apr2021 via nasal swab.
Localized redness and swelling at the site on injection for 3 days along with soreness
2/17/23 I started with a cough and it progressively got worse. Around day 4 or 5, I had a serious sinus headache, my face hurt really bad. No fever. I was having bad coughing fits and had to use my rescue inhaler quite frequently. I was on a cruise, so did not call my doctor's office. I took cough drops, BENADRYL and TYLENOL. My throat is still raspy, and I am coughing, not quite as bad. I am not using my rescue inhaler as much.
Heart pounding, palpitations  day 3-4.  Decreased hearing  after shot #2 given on 03/29/2021.  Increased joint pain in right hip after second shot. Noticed pain increase about first week of May, 2021.
Myalgia; diarrhea; fever 102.6 5/23, then resolved; arm redness and swelling 5/23 x 2d then better. Exam 3.5 cm area around injection. Pink, not warm tender.
low platelets--in and out of emergency room, doctors, horrible pain needing chemo starting thursday going up and down depending on meds
osteoarthritis flare is severe pain, generalized in joints and soft tissue.; brain fog to date; dry sinuses; Joint pain; immediate sharp pain down left arm to wrist and across clavicle into lymph node with immediate swelling of node.; immediate sharp pain down left arm to wrist and across clavicle into lymph node with immediate swelling of node.; immediate sharp pain down left arm to wrist and across clavicle into lymph node with immediate swelling of node.; immediate sharp pain down left arm to wrist and across clavicle into lymph node with immediate swelling of node.; Taste the chemical ingratiates; 100 temp/temp 99.9; muscles/body aches; muscles/body aches; diarrhea; This is a spontaneous report from a non-contactable consumer (patient). A 53-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot Number: ER8736) via an unspecified route of administration, administered in Arm Left on 02Aug2021 at 10:30 (age at vaccination was 53 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history included osteoarthritis (OA) and allergies: several. The concomitant medications were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no other medications was received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Aug2021, the patient experienced immediate sharp pain down left arm to wrist and across clavicle into lymph node with immediate swelling of node, taste the chemical ingratiates, 100 temp/temp 99.9, muscles/body aches and diarrhea. On 03Aug2021, the patient experienced brain fog to date, dry sinuses, joint pain and increasing (L) lymph node swelling and pain. On 04Aug2021, the patient experienced osteoarthritis flare is severe pain, generalized in joints and soft tissue. The events resulted in doctor or other healthcare professional office/clinic visit on an unspecified date. The patient underwent lab tests and procedures which included temperature was 100 on 02Aug2021 and 99.9 on 03Aug2021. Therapeutic measures were taken as a result of events Voltaren for 5 days, Tylenol fore fever, penetrex for muscles aches, an unspecified supplements and pushed fluids 8/7 at outstanding SEs: for brain fog and (L) lymph node swelling. PCP was notified. Forced to call out from work. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Headache and nausea started around 9 hours after shot. (3am). Vomiting started at 8am. (14 hours after shot).  Puked about a dozen times. Stopped puking at 7pm. Started to feel a little better and ate a little at 8pm.  Next day felt woozy, but no puking. General fatigue setting in mid afternoon for a week so far.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 87-year-old female patient who received SHINGRIX for prophylaxis. On 19th February 2019, the patient received the 2nd dose of SHINGRIX. On 19th February 2019, less than a day after receiving SHINGRIX, the patient experienced pain in arm. The patient was treated with Ice Pack (No Medication) and TYLENOL. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The patient had arm achy very much. The patient asking any relief suggestions. The patient did ice for a half and an hour, and took one TYLENOL.
Sore; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient experienced sore arms after receiving the Shingrix vaccine. The reporter did not consent to follow up. The reporter was unable to obtain additional information. This case has been linked with cases US2019125903, US2019125907, US2019125910, reported by the same reporter.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 28-DEC-2015, the patient was vaccinated with a dose of VAQTA injection (dose, route of administration, administration site, lot # and expiry date were not specified. On 14-APR-2016, the patient was vaccinated with another dose of VAQTA (dose, route of administration, administration site, lot # and expiry date were not reported). No adverse symptoms were reported. Product quality complaint (PQC) was not involved. Additional information is not expected as there was no consent for further contact.
ACHE; DIZZY; FOGGY; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-MAR-2021, the subject experienced ache. On 15-MAR-2021, the subject experienced dizzy. On 15-MAR-2021, the subject experienced foggy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from ache, dizzy, and foggy. This report was non-serious.
Pfizer-BioNTech COVID-19 Vaccine EUA. Muscle pain, joint pain, lymph node pain, fever, profuse sweating. Duration: 40 hrs.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. On 17-DEC-2014, the patient was vaccinated with a dose of RECOMBIVAX HB (lot # reported as L5MN2 exp date 02-SEP-2016) instead of GARDASIL in error. The patient received the first dose of GARDASIL on 04-NOV-2014 and did not receive her second dose of GARDASIL at this time due to the error. No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Severe fatigue  Severe confusion, ?brain fog? Chills Fever Diarrhea Muscle fatigue Joint pain
Started developing a cough 2 days post COVID-19 exposure. Tested negative on at home test. Went to walk in clinic and was told to retest for COVID-19 in 24 hours. Retested the next day and it was positive. Symptoms persisted for two weeks before I started to feel better. Symptoms have mostly resolved, still missing a few tastes and smells. Been experiencing severe insomnia ever since having COVID-19.
Burning upon administration of injection, a bunch developed at the site; I iced it; then redness in a sphere around injection site; by morning the redness was about 4 inches wide; seemed hot and it was itchy.  I took tylenol; iced the location; used Benadryl spray.  Wednesday was most itchy; red area started declining Thursday; smaller red area Friday, less itching; by Saturday no itching.  Today, Sunday, 10/4 there is a 2" circular area that is discolored, like a bruise.  it is tender but does not itch and I do not need ice.
Patient expressed continued ongoing pain in arm where injection of Shingrix was done. Has been ongoing issue 2 months after injection. Current treatment unknown, however patient mentioned might be doing rehab on arm in the future.
pt recv vax & devel t106-ear w/in 1hr of vax;had swelling of lt arm to elbow for 5 days & took a month for entire swelling to go away;
contracted shingles on his leg; has high anxiety; rash; blisters; it was hard to lift anything; felt that he had got punched in his arm; This case was reported by a consumer and described the occurrence of shingles in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 4 months ago (from the day of reporting)). Concurrent medical conditions included hiv infection.   On 17th December 2021, the patient received the 2nd dose of Shingrix. On 17th December 2021, less than a day after receiving Shingrix, the patient experienced pain in arm and injected limb mobility decreased. On 20th December 2021, the patient experienced shingles, anxiety, rash and blister. On an unknown date, the outcome of the shingles, anxiety, rash and blister were not recovered/not resolved and the outcome of the pain in arm and injected limb mobility decreased were unknown.   It was unknown if the reporter considered the shingles, pain in arm, anxiety, injected limb mobility decreased, rash and blister to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The reporter stated that he had his second dose of Shingrix on the left deltoid, he felt that he had got punched in his arm and it was hard to lift anything. On the day of reporting, the patient contracted Shingles on his leg with rash and blisters. The reporter also stated that he had high anxiety. The reporter had limited information. The reporter consented to follow up with himself and with pharmacy
In first minute after vaccine administration patient developed redness, swelling, warmth at injection site. She started having nausea and vomiting and was noted to have tachycardia. Within the first 5 minutes patient started developing shortness of breath and sensation of face and throat swelling. Patient was given a dose of IM epinephrine and transferred to the ED. In the ED patient was monitored and given IV fluids. No additional doses of Epinephrine have been given and patient is recovering no longer having throat swelling or shortness of breath.
Information has been received from a physician concerning an 80 year old female with hypothyroidism and skin disorder who on 10-JUN-2008 was vaccinated with a dose of ZOSTAVAX (lot number 659407/0295X) (injection site and route not reported). Concomitant therapy included SYNTHROID. On 24-JUN-2008 the patient experienced lightheadedness and difficulty with exercise. An electrocardiogram showed heart block. The patient was treated at the hospital and had a pacemaker placed. Subsequently, the patient recovered from the events. The reporter felt that heart block was probably not related to therapy with ZOSTAVAX. According to the physician, the lightheadedness, difficulty with exercise, heart block and given of an elective pace maker were considered to be other important medical events. Additional information has been requested.
Patient reported 2 weeks of chest tightness and feeling generally unwell right after vaccine. She didn't see any medical professional for these s/s and reported symptoms 1 year after vaccine.
pt recvd vax & devel local rxn characterized by edema, redness & warmth;
RASH AND ITCHING OVER FACE ARMS CHEST BACK. SEEN BY DR. 10ML OF BENADRYL GIVEN PO PER DR. DR. INSTRUCTED MOTHER TO GIVE ANOTHER DOSE IN 6 HRS. IF CHILD GET WORST TO GO TO THE HOSPITAL.  CHILD LEFT ABOUT 4:45 NAD.
My adverse event started after 3 month of receiving  my  5th  Pfizer Bivalent Booster which is on 12/11/2022 at noon.  I felt my heart skipping beats. I called  my doctor on Monday 12/12/2022  and schedule an appointment on  01/25/2023. They called and scheduled an appointment with the Cardiologist the same day. They ordered an Holter Monitor which I wore for a week. They diagnosed me with PBCC on 02/28/2023.  They told me that I had Premature Ventricular contractions, TAC of a low burden and some episodes of SVCS. They advised  me to take Metoprolol as per needed, increase potassium and stay hydrated.   I get Arrhythmia every once in a while. It's really annoying.
Initial misuse report received from a none-healthcare professional on 04 October 2013. The patient had received FLUZONE. The patient received FLUZONE in gluteal area.  (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
No adverse event; They accidentally administered a patient with the Moderna Covid 19 bivalent as a primary dose.; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (They accidentally administered a patient with the Moderna Covid 19 bivalent as a primary dose.) and NO ADVERSE EVENT (No adverse event) in an 18-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 020H22A) for COVID-19 prophylaxis.     There was no parental vaccine exposure.     On 22-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 22-Nov-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (They accidentally administered a patient with the Moderna Covid 19 bivalent as a primary dose.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (They accidentally administered a patient with the Moderna Covid 19 bivalent as a primary dose.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (They accidentally administered a patient with the Moderna Covid 19 bivalent as a primary dose.).    No concomitant medications were reported.   No treatment details were reported.
This case was reported by a healthcare professional and described the occurrence of fever in a 22-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). Concurrent medical conditions included post-partum. Concurrent medications include Lortab. On an unspecified date in 2010 he subject received unspecified dose of BOOSTRIX (unknown). Approximately two days after vaccination with BOOSTRIX, the subject experienced fever, vomiting, malaise and headache. According to the sales representative BOOSTRIX was administered postpartum. At the time of reporting the outcome of the fever, vomiting, malaise and headache were unspecified. Follow-up information received from th healthcare professional on 13 October 2010: It was reported that the subject had not received BOOSTRIX previously. The BOOSTRIX was administered to the subject while she was hospitalized post-delivery. The subject experienced fever, vomiting, malaise and headache on 06 May 2010. The events resolved on 10 May 2010.  The reporter considered that the events were possibly related to the BOOSTRIX. Treatment medications included Rocephin for fever of unknown origin and Amoxicillin for fever of unknown origin and possible endometritis.
MMR last 5/20 then see rashes red and raised on chest, abdomen, back C/O itchiness 5/24. Started BENADRYL 25 mg daily on 5/25 hydrocortisone 1% cream twice a day. Increase to steroid cream and added ZYRTEC.
At midnight after the shot I developed 99.9, chills, myalgia, severe migraine and all of it lasted 16 hours. I reported it to the nurse practitioner but did not want to see her because I knew it would resolve. I am a nurse and expected it would improve on it's own and it did. I did take Tylenol  for the symptoms when they began. I work in a clinic.
patient complained of severe muscle pain and difficulty moving arm for more than a week after shot. Patient refused to see medical doctor to evaluate
Headache, Fever, Chills, Fatigue, Stomach ache, nausea